Antibiotics for treatment of acute respiratory tract infections: Decreasing benefit, increasing risk, and the irrelevance of antimicrobial resistance

Research output: Contribution to journalComment/debatepeer-review

49 Scopus citations
Original languageEnglish (US)
Pages (from-to)744-746
Number of pages3
JournalClinical Infectious Diseases
Volume47
Issue number6
DOIs
StatePublished - Sep 15 2008

Funding

Potential conflicts of interest. J.A.L. has received grant support from Roche and Pfizer.

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this